Minority Diabetes Reports
Wednesday, October 23rd, 2013
Diabetes Care October 21, 2013 OBJECTIVE To develop a New Chinese Diabetes Risk Score for screening undiagnosed type 2 diabetes in China. RESEARCH DESIGN AND METHODS Data from the China National Diabetes and Metabolic Disorders Study conducted from June 2007 to May 2008 comprising 16,525 men and 25,284 women aged 20–74 years were analyzed. Undiagnosed type 2 diabetes […]
Minority Diabetes Reports
Wednesday, October 23rd, 2013
Diabetes Care October 15, 2013 Objective This cross-sectional clinical study compared the pathophysiology of type 2 diabetes in Japanese and Caucasians and investigated the role of demographic, genetic, and lifestyle-related risk factors for insulin resistance and beta-cell response. Research Design and Methods A total of 120 Japanese and 150 Caucasians were enrolled to obtain comparable distributions of high/low […]
Minority Diabetes Reports
Wednesday, October 23rd, 2013
Diabetes Care October 15, 2013 Objective Clinical trials to date have not provided definitive evidence regarding the effects of glucose lowering with coronary heart disease (CHD) risk among diabetic patients. Research Design and Methods We prospectively investigated the association of HbA1c at baseline and during follow-up with CHD risk among 17,510 African American and 12,592 White patients with […]
Minority Diabetes Reports
Wednesday, October 23rd, 2013
American Journal of Public Health: 8/15/ Objectives. We assessed whether community health workers (CHWs) could improve glycemic control among Mexican Americans with diabetes. Methods. We recruited 144 Mexican Americans with type 2 diabetes between January 2006 and September 2008 into the single-blinded, randomized controlled Mexican American Trial of Community Health Workers (MATCH) and followed them for 2 years. […]
Minority Diabetes Reports
Wednesday, October 23rd, 2013
American Journal of Public Health: 6/13/13 Objectives. We evaluated the effectiveness of a community-based healthy lifestyle intervention in improving dietary behaviors of pregnant Latinas from 2004 to 2006 in Detroit, Michigan. Methods. The 11-week, culturally tailored, Spanish-language Healthy Mothers on the Move (MOMs) intervention offered home visits, group classes, related activities, and social support from trained community […]
Clinical Trial News
Wednesday, October 23rd, 2013
Medical News Today: 10/23/13 A research team led by Anastassios G. Pittas, MD, MS, Endocrinologist and Co-Director of the Diabetes Center at Tufts Medical Center in Boston, has received a National Institutes of Health (NIH) grant of more than $40 million over five years to conduct the Vitamin D and Type 2 diabetes (D2d) study.* D2d is a nationwide clinical […]
Clinical Trial News
Wednesday, October 23rd, 2013
Diabetes Care: October 21, 2013 OBJECTIVE —To assess the efficacy and safety of dapagliflozin as add-on therapy in patients with type 2 diabetes who were inadequately controlled with a dipeptidyl peptidase-4 inhibitor with or without metformin. RESEARCH DESIGN AND METHODS —In this 24-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase 3 study with a 24-week blinded extension period, 432 […]
Clinical Trial News
Wednesday, October 23rd, 2013
Diabetes Care October 21, 2013 OBJECTIVE To assess the efficacy and safety of 32 mg naltrexone sustained-release (SR)/360 mg bupropion SR (NB) in overweight/obese individuals with type 2 diabetes with or without background oral antidiabetes drugs. RESEARCH DESIGN AND METHODS This was a 56-week, double-blind, placebo-controlled study in which 505 patients received standardized lifestyle intervention and were randomized […]
Clinical Trial News
Wednesday, October 23rd, 2013
The Lancet Diabetes & Endocrinology, Early Online Publication, 18 October 2013 Background Metformin is the only first-line oral hypoglycaemic drug for type 2 diabetes recommended by international guidelines with proven efficacy, safety, and cost-effectiveness. However, little information exists about its use in Asian populations. We aimed to ascertain the effectiveness of the α-glucosidase inhibitor acarbose, […]
Clinical Trial News
Wednesday, October 23rd, 2013
Diabetes Care: October 15, 2013 OBJECTIVE The purpose of this randomized controlled trial was to investigate the dose-response effect of fruit and vegetable (F&V) intake on insulin resistance (IR) in people who are overweight and at high risk of cardiovascular disease (CVD). RESEARCH DESIGN AND METHODS A total of 105 participants (mean age 56 years) followed a 4-week […]
